NORTHWEST BIOTHERAPEUTICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Northwest Biotherapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Northwest Biotherapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$19.4M, a 17.6% increase year-over-year.
  • Northwest Biotherapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$69.5M, a 9.61% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$62.6M, a 40.4% increase from 2022.
  • Northwest Biotherapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$105M, a 159% decline from 2021.
  • Northwest Biotherapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was $179M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$69.5M -$19.4M +$4.15M +17.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$73.7M -$17.9M -$3.42M -23.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$70.3M -$18.3M -$7.66M -71.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$62.6M -$14M +$14.3M +50.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$76.9M -$23.5M +$9.33M +28.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$86.3M -$14.4M +$15.2M +51.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$101M -$10.7M +$3.56M +25.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$105M -$28.3M -$162M -121% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $56.6M -$32.9M -$78.4M -172% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $135M -$29.7M -$34.1M -773% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $169M -$14.2M -$10.1M -245% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $179M $133M +$414M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$234M $45.5M +$240M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$474M $4.41M +$62.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$537M -$4.12M -$6.75M -257% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$530M -$280M -$287M -4559% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$243M -$194M -$188M -2947% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$55.5M -$58.1M -$58.3M -26608% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $2.76M $2.63M +$23.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$20.8M $6.29M +$11.9M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$32.7M -$6.37M -$18.9M -151% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-15
Q2 2019 -$13.8M $219K +$21.4M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$35.2M -$20.9M +$599K +2.78% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-24
Q4 2018 -$35.8M -$5.65M +$21.3M +79.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$57.1M $12.6M +$35.8M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$93M -$21.2M -$10.9M -107% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$82.1M -$21.5M -$8.93M -70.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$73.1M -$27M +$3.71M +12.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-02
Q3 2017 -$76.9M -$23.3M +$5.96M +20.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$82.8M -$10.3M +$3.92M +27.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$86.7M -$12.6M -$6.51M -107% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-16
Q4 2016 -$80.2M -$30.7M -$6.63M -27.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$73.6M -$29.2M -$51.8M -229% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$21.7M -$14.2M +$52.7M +78.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$74.4M -$6.11M +$40.3M +86.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$115M -$24.1M +$18.6M +43.6% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-16
Q3 2015 -$133M $22.6M +$43.7M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$177M -$66.8M -$41M -158% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$136M -$46.4M -$392K -0.85% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$136M -$42.7M -$25.8M -153% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-16
Q3 2014 -$110M -$21M +$1.87M +8.15% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-16
Q2 2014 -$112M -$25.9M -$14.3M -123% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-16
Q1 2014 -$97.4M -$46M -$31.6M -220% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-16
Q4 2013 -$65.8M -$16.9M +$13.6M +44.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-16
Q3 2013 -$79.4M -$22.9M -$6.42M -38.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 -$73M -$11.6M -$1.44M -14.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-15
Q1 2013 -$71.6M -$14.4M -$4.24M -41.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$67.3M -$30.5M -$17.9M -143% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-01
Q3 2012 -$49.4M -$16.5M -$17M -3522% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 -$32.4M -$10.2M +$2.18M +17.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$34.6M -$10.2M -$1.74M -20.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$32.8M -$12.6M Oct 1, 2011 Dec 31, 2011 10-K 2014-04-01
Q3 2011 $482K +$5.86M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$12.3M -$3.6M -41.3% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-12
Q1 2011 -$8.41M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 -$5.38M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$8.73M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.